Study objective: To compare the safety of salmeterol xinafoate or placebo added to usual asthma care. Design: A 28-week, randomized, double-blind, placebo-controlled, observational study.

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...

A quarter of the 2025 Formula 1 grid is made up of drivers who have not held a full-time seat before, and they boast a combined four grand (…) ...

The systemic effects seen over eight hours after inhalation of three doses of salmeterol and formoterol were therefore compared in normal subjects. RESULTS Both salmeterol and formoterol caused an ...

3 Department of Statistics (Research & Development), King’s College Hospital, London, UK Correspondence to: Dr W D C Man Respiratory Muscle Laboratory, Guy’s, King’s and St Thomas’ School of Medicine, ...

Formula E races are a high-speed game of chess with ...

Introduction: The incidence of asthma exacerbations in patients receiving salmeterol/fluticasone propionate (Seretide™ or Advair ®) is low. However, when asthma control deteriorates ...

Formula E is set to get a lot faster with the introduction of the GEN3 Evo, the quickest accelerating FIA single-seater race car – Capable of 0-60mph in 1.82 seconds (0-100kph in 1.86s). Set to race ...

© 2025 BBC. The BBC is not responsible for the content of external sites. Read about our approach to external linking.